RX Bioscience India Private Limited

RX Bioscience India Private Limited - professional services in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U73100TG2012PTC083411 Incorporated 04 October 2012 ROC Hyderabad HQ Hyderabad, Telangana, India
Struck Off Private Limited Company professional services
Revenue · FY 2018
₹86,786
▼ 58% YoY
Net loss · FY 2018
₹8.12 Lakh
Latest filing
EBITDA · FY 2018
-₹6.11 Lakh
Latest filing
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
Active GSTINs
1
of 2 registered

About RX Bioscience India Private Limited

Data last updated:

RX Bioscience India Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the personal services segment of the professional services sector. It was incorporated on 04 October 2012.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2012PTC083411. Its GSTIN is 36AAGCR0889P1ZK (Telangana). The company held 2 GST registrations, of which 1 is active.

The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh. It was led by directors including Jeyalekshmi Thanumalayan and Ebenezer Gnanaraj Moses.

Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 4 – 7 – 71 Flat No.417 Sai Durga Gardens Nacharam Uppal, Hyderabad, Telangana, India – 500076.

As per the financials filed for FY 2018, the company reported a revenue of ₹86,786, a decline of 58% compared to the previous year. For the same year it recorded a net loss of ₹8.12 Lakh and EBITDA of -₹6.11 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 30% over three years.

Company details

CIN U73100TG2012PTC083411
Registration Number 083411
Incorporation Date 04 October 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Compliance Status Active Non-Compliant

CIN history

RX Bioscience India has one previous CIN (Corporate Identification Number): U73100AP2012PTC083411. The current CIN is U73100TG2012PTC083411, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U73100TG2012PTC083411Current
U73100AP2012PTC083411Previous

Contact details

RX Bioscience India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    4 – 7 – 71 Flat No.417 Sai Durga Gardens Nacharam Uppal, Hyderabad, Telangana, India – 500076
  • Industry
    Professional Services, Personal, Scientific, Technical

To see the full contact details of RX Bioscience India Private Limited, buy the company report.

Comprehensive company report
RX Bioscience India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of RX Bioscience India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of RX Bioscience India Private Limited, buy the company report.

Financials of RX Bioscience India Private Limited

FY 2018 filings available

RX Bioscience India Private Limited reported revenue of ₹86,786 (down 58% YoY) for FY 2018.

Revenue · FY 2018
₹86,786 ▼ 58%
Net loss · FY 2018
₹8.12 Lakh
EBITDA · FY 2018
-₹6.11 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 58%
3 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▲ 28%
3 years · compounded
▼ 16%

Revenue has declined at a compounded annual rate (CAGR) of 30% over three years, including a 58% fall in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹6.11 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.12 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of RX Bioscience India Private Limited, buy the company report.

Board of directors of RX Bioscience India Private Limited

RX Bioscience India has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Jeyalekshmi ThanumalayanDirector15 Jul 201313 Years 4 MonthsAs last reported
Ebenezer Gnanaraj MosesDirector04 Oct 201214 Years 1 MonthsAs last reported
Anwar Hamid QaziDirector04 Oct 201214 Years 1 MonthsAs last reported

Peer comparison

RX Bioscience India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Satyam Technosys Private Limited₹87,267 (FY 2024)13.0%New Delhi, Delhi, India
Vr3 Business Services Private Limited₹87,165 (FY 2022)-30.0%Bangalore, Karnataka, India
Ethical Goldcruise Solutions Private Limited₹87,156 (FY 2021)Delhi, India
Fluidesk Technologies Private Limited₹87,100 (FY 2025)8.0%Pune, Maharashtra, India
Atlas Telecommunications Private Limited₹87,087 (FY 2020)-57.0%Mumbai, Maharashtra, India
RX Bioscience India Private Limitedthis company₹86,786 (FY 2018)-₹8.12 Lakh-58.0%Hyderabad, Telangana, India
Riseup Technologies Private Limited₹86,700 (FY 2019)53.0%Pune, Maharashtra, India
Edupedia Educational Services Private Limited₹86,681 (FY 2021)Kolkata, West Bengal, India
Minto Consultancy Services Private Limited₹86,571 (FY 2025)-75.0%Badaun, Uttar Pradesh, India
Nibiaa Consultancy Private Limited₹86,555 (FY 2025)-69.0%Po Singjamei, Imphal East, Manipur, India
Corecti Software Private Limited₹86,551 (FY 2024)-13.0%Hyderabad, Telangana, India

To see the full peer comparison of RX Bioscience India Private Limited, buy the company report.

Auditor

RX Bioscience India Private Limited is audited by RAJSEKHARA & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
RAJSEKHARA & ASSOCIATESFY 2017011714S

Shareholding

The shareholding of RX Bioscience India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of RX Bioscience India Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for RX Bioscience India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

RX Bioscience India has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAGCR0889P1ZKTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of RX Bioscience India Private Limited, buy the company report.

Recent activity

RX Bioscience India Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Jeyalekshmi Thanumalayan ceased to be Additional Director on 30 Sep 2014.

AGM
Rx Bioscience India Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Filing
Rx Bioscience India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad.
Ceased
Jeyalekshmi Thanumalayan ceased to be Additional Director.
Appointed
Jeyalekshmi Thanumalayan was appointed as Director.
Appointed
Anwar Hamid Qazi was appointed as Director.
Appointed
Ebenezer Gnanaraj Moses was appointed as Director.
Incorporation
04 Oct 2012
Rx Bioscience India Private Limited was registered on 04 Oct 2012 with Roc Hyderabad & aged 14 years 1 month as per MCA records.

Frequently asked questions

RX Bioscience India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

RX Bioscience India was a private limited company based in Hyderabad, Telangana, India. The company worked in personal, within the professional services industry. It was incorporated on 04 October 2012 and is registered under CIN U73100TG2012PTC083411. The company has been struck off by the Registrar of Companies and is no longer operational.

RX Bioscience India had 3 directors:

The CIN (Corporate Identification Number) of RX Bioscience India is U73100TG2012PTC083411. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of RX Bioscience India is at 4 – 7 – 71 Flat No.417 Sai Durga Gardens Nacharam Uppal, Hyderabad, Telangana, India – 500076.

RX Bioscience India was incorporated on 04 October 2012. It is registered with the Registrar of Companies, Hyderabad.

The latest financial statements of RX Bioscience India on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.

The GSTIN of RX Bioscience India is 36AAGCR0889P1ZK, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

RX Bioscience India operated in the professional services industry, in the personal segment. It worked in this industry before it was struck off.

The peers of RX Bioscience India by revenue are Satyam Technosys Private Limited, Vr3 Business Services Private Limited, Ethical Goldcruise Solutions Private Limited, Fluidesk Technologies Private Limited, Atlas Telecommunications Private Limited and 5 more, all in the same principal business activity (other professional, scientific and technical activities).

Jeyalekshmi Thanumalayan ceased to be Additional Director on 30 Sep 2014. Jeyalekshmi Thanumalayan was appointed as Director on 15 Jul 2013. Anwar Hamid Qazi was appointed as Director on 04 Oct 2012. RX Bioscience India has 4 board changes on record in total.